CINECA IRIS Institutional Research Information System

RICCI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.720
AS - Asia 4.117
EU - Europa 2.556
SA - Sud America 827
AF - Africa 299
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.529
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.240
CA - Canada 2.429
SG - Singapore 1.358
CN - Cina 1.082
HK - Hong Kong 752
IT - Italia 718
BR - Brasile 689
VN - Vietnam 445
DE - Germania 419
SE - Svezia 306
BG - Bulgaria 223
GB - Regno Unito 194
CI - Costa d'Avorio 165
RU - Federazione Russa 156
FR - Francia 154
FI - Finlandia 114
TR - Turchia 79
IN - India 78
JP - Giappone 61
AT - Austria 53
BD - Bangladesh 49
AR - Argentina 45
IQ - Iraq 43
UA - Ucraina 39
ES - Italia 32
NL - Olanda 31
ZA - Sudafrica 28
ID - Indonesia 26
KR - Corea 25
NG - Nigeria 25
SN - Senegal 24
MX - Messico 23
CH - Svizzera 21
EC - Ecuador 19
BE - Belgio 18
VE - Venezuela 18
PL - Polonia 17
PK - Pakistan 15
UY - Uruguay 14
CO - Colombia 13
SA - Arabia Saudita 13
KE - Kenya 11
PH - Filippine 11
MA - Marocco 10
MY - Malesia 10
PY - Paraguay 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
IE - Irlanda 9
EG - Egitto 8
NP - Nepal 8
AZ - Azerbaigian 7
CL - Cile 7
GR - Grecia 7
IL - Israele 7
JO - Giordania 7
PE - Perù 7
CR - Costa Rica 6
LT - Lituania 6
TN - Tunisia 6
BO - Bolivia 5
ET - Etiopia 5
HU - Ungheria 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
IR - Iran 4
AO - Angola 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
KZ - Kazakistan 3
NI - Nicaragua 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
DZ - Algeria 2
EU - Europa 2
KG - Kirghizistan 2
LY - Libia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
TG - Togo 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
Totale 18.511
Salva come PNG Salva come JPEG
Città #
Montreal 2.316
Ashburn 849
Singapore 747
Hong Kong 736
Woodbridge 625
Fairfield 605
Dallas 589
Houston 571
Santa Clara 560
San Jose 526
Ann Arbor 497
Chandler 423
Seattle 312
Shanghai 290
Beijing 249
Wilmington 241
Sofia 222
Cambridge 205
New York 188
Abidjan 165
Los Angeles 129
Serra 125
Ho Chi Minh City 124
Boardman 123
Princeton 113
Lawrence 97
Medford 86
Lauterbourg 85
Milan 80
Ottawa 80
Hanoi 76
Munich 68
Florence 67
São Paulo 56
Council Bluffs 53
Des Moines 52
Tokyo 52
Rome 47
Redondo Beach 46
Hefei 45
Buffalo 44
Jacksonville 42
Vienna 42
Istanbul 40
Ogden 39
Turku 39
Frankfurt am Main 37
Lancaster 35
Dong Ket 34
Nanjing 34
San Diego 34
London 33
Pisa 28
Lagos 25
Columbus 24
Dakar 24
Helsinki 24
The Dalles 23
Bremen 22
Rio de Janeiro 22
Chicago 21
Seoul 20
Izmir 19
Shenyang 19
Da Nang 18
Hebei 18
Nanchang 18
Redwood City 18
Orem 17
Belo Horizonte 16
Brussels 16
Dearborn 16
Düsseldorf 16
Haiphong 16
Nuremberg 16
Madrid 15
Fuzhou 14
Jiaxing 14
Johannesburg 14
San Francisco 14
Baghdad 13
Norwalk 13
Warsaw 13
Zurich 13
Genoa 12
Kunming 12
Montevideo 12
Nürnberg 12
Phoenix 12
Toronto 12
Brooklyn 11
Jüchen 11
Atlanta 10
Campinas 10
Curitiba 10
Dhaka 10
Guangzhou 10
Guayaquil 10
New Delhi 10
Porto Alegre 10
Totale 13.726
Salva come PNG Salva come JPEG
Nome #
A Clinical Tool for Prognosis and Speech Rehabilitation in Dysarthric Patients: The DESIRE Project 2.543
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease 297
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 280
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family 240
Metabolic myopathies: functional evaluation by different exercise testing approaches 232
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 223
Pes cavus and hereditary neuropathies: when a relationship should be suspected. 206
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 205
Inflammatory myopathy in a patient with postural and kinetik tremor. 203
Physical exercise and oxidative stress in muscular dystrophies: is there a good balance? Exercise and oxidative stress in MDs 202
Astrocyte-neuron interactions in neurological disorders 199
Mitochondria and neurodegeneration 198
A personal monitoring architecture to detect muscular fatigue in elderly. 196
Congenital myopathies: Clinical phenotypes and new diagnostic tools 194
Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment. 193
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. 192
Study of the porcine dermal collagen repair patch in morpho-functional recovery of the rotator cuff after minimum follow-up of 2.5 years 189
NMR voxel-based morphometry and functional analysis as neural correlates of neuropsychological dysfunction in DM1 182
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study 179
Cross-talk between pathogenic mechanisms in neurodegeneration: the role of oxidative stress in Amyotrophic Lateral Sclerosis 178
A mobile app for patients with Pompe disease and its possible clinical applications 178
ClC-1 mutations in myotonia congenita patients: Insights into molecular gating mechanisms and genotype-phenotype correlation 176
A pervasive activity management and rehabilitation support system for the elderly 176
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 175
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy. 172
Folate, homocysteine, vitamin B12 and polymorphisms of genes participating in one-carbon metabolism in late onset Alzheimer's disease patients and healthy controls. 172
The proposal of a clinical protocol to assess central and peripheral fatigue in myotonic dystrophy type 1 169
Next-generation sequencing identifies transportin 3 as the causative gene for LGMD1F. 167
Expanding the clinical and genetic spectrum of pathogenic variants in STIM1 167
A wearable pervasive platform for intelligent monitoring of muscular fatigue 165
Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies 165
Prevalent cardiac phenotype resulting in heart transplantation in a novel LMNA gene duplication 160
LMNA-associated myopathies: the Italian experience in a large cohort of patients 156
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. 154
Tubular Aggregates Myopathy: case description 152
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry 149
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. 147
Characterization of Phenotypic Variability in Becker Muscular Dystrophy for Clinical Practice and Towards Trial Readiness: A Two-Years Follow up Study 145
Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for "double trouble" overlapping syndromes 145
Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients 144
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group. 143
A novel family with axonal Charcot-Marie-Tooth disease caused by a mutation in the EGR2 gene 143
Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy 142
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study 142
CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers. 141
Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. 141
D4Z4 reduced allele in myopathic subjects with no FSHD phenotype: why inconsistency between molecular and clinical data should prompt us to further investigations. 138
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. 136
A multi-parametric protocol to study exercise intolerance in McArdle's disease 135
Hard ways towards adulthood: the transition phase in young people with myotonic dystrophy 135
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 133
The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients 133
The role of magnetic resonance imaging in the diagnostic work-out of myopathies: differential diagnosis between inflammatory myopathies and muscular dystrophies 131
Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes 131
Exercise-Related Oxidative Stress as Mechanism to Fight Physical Dysfunction in Neuromuscular Disorders 130
An Ontology-driven Multisensorial Platform to Enable Unobtrusive Human Monitoring and Independent Living 129
The empowerment of translational research: lessons from laminopathies 129
"I have got something positive out of this situation": Psychological benefits of caregiving in relatives of young people with muscular dystrophy 127
A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates 126
Novel LMNA gene mutation in a patient with cardiac and skeletal muscle involvement 123
Facioscapulohumeral muscular dystrophy: New insights from compound heterozygotes and implication for prenatal genetic counselling 122
A case of intravascular large B cell lymphoma with brain involvement mimicking progressive multifocal leukoencephalopathy 122
A Single mtDNA Deletion in Association with a LMNA Gene New Frameshift Variant: A Case Report 121
Exercise therapy in muscle diseases: open issues and future perspectives 118
Natural history of Becker muscular dystrophy: DMD gene mutations predict clinical severity 116
Facioscapulohumeral muscular dystrophy: more complex than it appears 116
Convolutional Neural Network-Based Automated Segmentation of Skeletal Muscle and Subcutaneous Adipose Tissue on Thigh MRI in Muscular Dystrophy Patients 114
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis 114
Cardiac magnetic resonance in patients with muscular dystrophies 114
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1 113
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 112
Mutations in glycyl-tRNA synthetase impair mitochondrial metabolism in neurons 111
A 5-year clinical follow-up study from the Italian National Registry for FSHD 111
Biomolecules of Muscle Fatigue in Metabolic Myopathies 109
Phenotype may predict the clinical course of facioscapolohumeral muscular dystrophy 108
Fatigue as a common signature of inflammatory myopathies: clinical aspects and care 107
Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still "invisible"? 105
Pathophysiology and Management of Fatigue in Neuromuscular Diseases 104
FUNCTIONAL DIAGNOSTICS IN MITOCHINDRIAL DISEASES 104
Nusinersen treatment and cerebrospinal fluid neurofilaments: An explorative study on Spinal Muscular Atrophy type 3 patients 103
Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillar and Distal Myopathies 102
Chronic inflammatory demyelinating polyneuropathy associated with multiple sclerosis 101
Posterior reversible encephalopathy syndrome in a complicated autoimmune background: Differential diagnosis and etiological hypothesis 100
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs) 99
Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen 98
Cardiac comorbidities in McArdle disease: case report and systematic review 98
Mitochondrial DNA transcription and translation: Clinical syndromes 97
Integrating D4Z4 methylation analysis into clinical practice: improvement of FSHD molecular diagnosis through distinct thresholds for 4qA/4qA and 4qA/4qB patients 96
The use of digital tools in rare neurological diseases towards a new care model: a narrative review 96
The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME 95
Telemedicine and remote monitoring in neuromuscular diseases: Challenges and opportunities 94
Intravenous immunoglobulin in the treatment of sporadic inclusion body myositis: time for new evidence? 94
Response. 92
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 91
Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients 91
Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report 90
null 88
Proposal of a new clinical protocol for evaluating fatigability in adult SMA patients 87
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 87
Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019) 87
Totale 16.580
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022983 21 48 23 69 161 129 27 51 45 41 73 295
2022/20231.390 151 175 87 104 149 149 10 100 320 8 109 28
2023/20243.170 46 75 85 32 121 132 98 39 26 2.333 63 120
2024/20253.666 13 125 84 193 398 408 343 205 348 468 368 713
2025/20264.945 317 587 701 548 448 403 658 261 285 450 184 103
2026/202737 37 0 0 0 0 0 0 0 0 0 0 0
Totale 18.724